Nakatoh S - Search Results

1

Real-world effectiveness of anti-osteoporosis medications for the prevention of incident hip and clinical vertebral fractures in patients on long-term glucocorticoid therapy: A nationwide health insurance claims database study in Japan.

Iki M, Fujimori K, Nakatoh S, Tamaki J, Ishii S, Okimoto N, Kamiya K, Ogawa S. Iki M, et al. Among authors: nakatoh s. Bone. 2023 Jan;166:116605. doi: 10.1016/j.bone.2022.116605. Epub 2022 Nov 5. Bone. 2023. PMID: 36347433

2

Application of the fracture risk assessment tool (FRAX(®)) and determination of suitable cut-off values during primary screening in specific health check-ups in Japan.

Nakatoh S, Takemaru Y. Nakatoh S, et al. J Bone Miner Metab. 2013 Nov;31(6):674-80. doi: 10.1007/s00774-013-0457-6. Epub 2013 Mar 30. J Bone Miner Metab. 2013. PMID: 23543192

3

The importance of assessing the rate of bone turnover and the balance between bone formation and bone resorption during daily teriparatide administration for osteoporosis: a pilot study.

Nakatoh S. Nakatoh S. J Bone Miner Metab. 2016 Mar;34(2):216-24. doi: 10.1007/s00774-015-0665-3. Epub 2015 Jun 2. J Bone Miner Metab. 2016. PMID: 26031934 Clinical Trial.

4

Effect of osteoporosis medication on changes in bone mineral density and bone turnover markers after 24-month administration of daily teriparatide: comparison among minodronate, raloxifene, and eldecalcitol.

Nakatoh S. Nakatoh S. J Bone Miner Metab. 2018 Mar;36(2):221-228. doi: 10.1007/s00774-017-0829-4. Epub 2017 Mar 14. J Bone Miner Metab. 2018. PMID: 28293779 Clinical Trial.

5

[Primary fracture prevention through the Osteoporosis Liaison Service.].

Nakatoh S. Nakatoh S. Clin Calcium. 2017;27(9):1233-1240. Clin Calcium. 2017. PMID: 28912385 Review. Japanese.

6

Estimates of hip fracture incidence in Japan using the National Health Insurance Claim Database in 2012-2015.

Tamaki J, Fujimori K, Ikehara S, Kamiya K, Nakatoh S, Okimoto N, Ogawa S, Ishii S, Iki M; Working Group of Japan Osteoporosis Foundation. Tamaki J, et al. Among authors: nakatoh s. Osteoporos Int. 2019 May;30(5):975-983. doi: 10.1007/s00198-019-04844-8. Epub 2019 Jan 16. Osteoporos Int. 2019. PMID: 30648192

7

Insufficient increase in bone mineral density testing rates and pharmacotherapy after hip fracture in Japan.

Nakatoh S, Fujimori K, Tamaki J, Okimoto N, Ogawa S, Iki M. Nakatoh S, et al. J Bone Miner Metab. 2020 Jul;38(4):589-596. doi: 10.1007/s00774-020-01093-2. Epub 2020 Mar 7. J Bone Miner Metab. 2020. PMID: 32146508

8

Insufficient persistence of and adherence to osteoporosis pharmacotherapy in Japan.

Nakatoh S, Fujimori K, Tamaki J, Okimoto N, Ogawa S, Iki M. Nakatoh S, et al. J Bone Miner Metab. 2021 May;39(3):501-509. doi: 10.1007/s00774-020-01188-w. Epub 2021 Jan 5. J Bone Miner Metab. 2021. PMID: 33403498

9

Insufficient increase in bone mineral density testing rates and pharmacotherapy after hip and vertebral fracture: analysis of the National Database of Health Insurance Claims and Specific Health Checkups of Japan.

Nakatoh S, Fujimori K, Ishii S, Tamaki J, Okimoto N, Ogawa S, Iki M. Nakatoh S, et al. Arch Osteoporos. 2021 Sep 12;16(1):130. doi: 10.1007/s11657-021-00992-9. Arch Osteoporos. 2021. PMID: 34510296

10

Insufficient persistence to pharmacotherapy in Japanese patients with osteoporosis: an analysis of the National Database of Health Insurance Claims and Specific Health Checkups in Japan.

Nakatoh S, Fujimori K, Ishii S, Tamaki J, Okimoto N, Ogawa S, Iki M. Nakatoh S, et al. Arch Osteoporos. 2021 Sep 13;16(1):131. doi: 10.1007/s11657-021-00993-8. Arch Osteoporos. 2021. PMID: 34515872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters